Our commitment is to improve lives by leveraging our cutting-edge technology to create innovative diagnostics.
SQI Diagnostics is a leading biotechnology research company committed to improving lives through innovative diagnostics. Leveraging cutting-edge technology, SQI Diagnostics discovers, develops, and commercializes rapid diagnostic testing solutions for healthcare providers, patients, and consumers across the globe.
SQI Diagnostics' proprietary advanced diagnostics target critical areas such as organ transplant, autoimmune disease, and COVID-19 testing. This includes the direct-to-consumer COVID-19 HOME Antibody Test, the RALI-dx™ COVID-19 Severity Triage Test, and the COVID-19 RALI-fast™ Severity Triage Point-of-Care (POC) Test. SQI Diagnostics is headquartered at 36 Meteor Dr, Toronto, ON M9W 1A4, CA.
SQI Diagnostics is dedicated to advancing precision medicine and delivering impactful healthcare solutions. We invite the management team at SQI Diagnostics to create a customized and exclusive company showcase and product listing on our platform to further highlight your innovative contributions to the biotechnology field.
SQI Diagnostics est une entreprise de premier plan dans le domaine de la recherche biotechnologique, engagée à améliorer la vie grâce à des diagnostics innovants. En tirant parti d'une technologie de pointe, SQI Diagnostics découvre, développe et commercialise des solutions de tests de diagnostic rapides pour les prestataires de soins de santé, les patients et les consommateurs du monde entier.
Les diagnostics avancés propriétaires de SQI Diagnostics ciblent des domaines critiques tels que la transplantation d'organes, les maladies auto-immunes et les tests COVID-19. Cela comprend le test d'anticorps COVID-19 HOME direct au consommateur, le test de triage de la gravité RALI-dx™ COVID-19 et le test de triage de la gravité au point de service (POC) RALI-fast™ COVID-19. Le siège social de SQI Diagnostics est situé au 36 Meteor Dr, Toronto, ON M9W 1A4, CA.
SQI Diagnostics se consacre à faire progresser la médecine de précision et à fournir des solutions de santé percutantes. Nous invitons l'équipe de direction de SQI Diagnostics à créer une vitrine d'entreprise et une liste de produits personnalisées et exclusives sur notre plateforme afin de mettre en évidence davantage vos contributions innovantes dans le domaine de la biotechnologie.
Compare SQI Diagnostics with 3 companies in Biotechnology-Research
| Comparison Field |
SQ
SQI DiagnosticsMain Company |
Somru BioScience Inc...View Profile |
Ultivue by VizgenView Profile |
Parean Biotechnologi...View Profile |
|---|---|---|---|---|
|
Founded Year
|
— | 2012 | 2020 | |
|
Company Size
|
— | 51-200 | 11-50 | 2-10 |
|
City
|
Toronto, ON | Charlottetown, Prince Edward Island | Cambridge, MA | |
|
Country
|
Canada | Canada | United States | |
|
Skills & Keywords
Comparing with main company
|
18 Total Skills
Biotechnology
Diagnostics
Precision Medicine
Organ Transplant
Autoimmune Disease
COVID-19 Testing
Healthcare Solutions
Immunogenicity
Clinical Diagnostics
Custom Assay Design
Covid 19 Testing
Lung Transplant Diagnostics
Biomarkers
Multiplexing
Bioanalytics
Organ Health
Home Health Testing
LigBinding Assays
|
13 Total
13 Unique
Unique Skills:
Aegyris™
AI Powered LIMS system
Amplatto™
Assay Development & Validation
Bioanalytical Testing
Bioassays
+7
|
11 Total
11 Unique
Unique Skills:
Assay Development
Digital Pathology
IHC
Image Analysis
Immunofluorescence
Immunohistochemistry
+5
|
14 Total
14 Unique
Unique Skills:
Artificial Intelligence
CarT Cell
Clinical Data Integration
Complex Biological Analysis
Computational Biology
DataScience
+8
|
Other organizations in the same industry
This company is also known as